A GlobalData study concludes that the pharmaceutical industry in Mexico will be worth around $22.5 billion by 2020. The anticipated market growth is driven by multiple factors including the North American Free Trade Agreement, government backing for health care, upgraded regulatory guidelines and the pervasiveness of noncommunicable diseases.

Full Story:

Related Summaries